Scientists test tiny 'Exosome' drug carriers in humans for first time
NCT ID NCT07219940
Summary
This is a very early, first-in-human study to check if a new type of drug called SOB100 is safe and how it moves through the body. SOB100 uses tiny natural particles called exosomes, designed to target a specific protein. The study will enroll 15 healthy volunteers to receive increasing doses and closely monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Parexel International - Baltimore Early Phase Clinical Unit
RECRUITINGBaltimore, Maryland, 21225, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.